Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AZTR
AZTR logo

AZTR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Azitra Inc (AZTR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.230
1 Day change
12.18%
52 Week Range
2.400
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Azitra Inc is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to invest. The stock is trading in a weak technical position, there are no strong proprietary buy signals, no recent news catalysts, no supportive analyst or insider buying trends, and no usable recent financial quarter data to justify an entry. Given the current setup and the user's need for a direct decision without waiting for a better entry, the clear call is to avoid buying now.

Technical Analysis

AZTR is showing a bearish-to-neutral technical profile. The MACD histogram is below zero and still negatively contracting, which points to weak momentum. RSI_6 at 47.499 is neutral, so there is no oversold rebound signal. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a downtrend structure. Price is hovering near the pivot at 0.20, with resistance at 0.22 and support at 0.179. The current price around 0.2052 is not giving a strong breakout or reversal confirmation.

Positive Catalysts

  • No news was reported in the past week, so there are no fresh event-driven positive catalysts. The stock trend model suggests some upside potential over longer horizons, with a projected 3.53% chance of move in the next week and 6.26% in the next month based on similar candlestick patterns, but this is not strong enough to override the weak technical setup.

Neutral/Negative Catalysts

  • There has been no recent news flow, no significant hedge fund activity, and no insider accumulation trend. The market is closed with only a marginal price change, and the stock remains in a weak technical configuration. The absence of recent congress trading activity also removes a potentially supportive signal. No option data is available to suggest bullish sentiment.

Financial Performance

Financial snapshot data was unavailable due to an error, so there is no latest quarter season financial basis to assess growth trends. Because the most recent quarter figures are not provided, there is no evidence here of improving revenue, margins, or earnings that would support a long-term beginner-friendly buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible Wall Street upgrade trend or bullish target revision to support the stock. Based on the available data, Wall Street sentiment appears neutral to negative by default, with no clear pros-side conviction. The cons view dominates: weak technicals, no news catalyst, no insider or hedge fund support, and no financial update to validate growth.

Wall Street analysts forecast AZTR stock price to rise
Analyst Rating
0
Wall Street analysts forecast AZTR stock price to rise
Buy
Hold
Sell
0
Current: 0.205
sliders
Low
0
Averages
0
High
0
0
Current: 0.205
sliders
Low
0
Averages
0
High
0
Maxim
Buy
downgrade
$4
AI Analysis
2025-09-24
Reason
Maxim
Price Target
$4
AI Analysis
2025-09-24
downgrade
Buy
Reason
Maxim lowered the firm's price target on Azitra to $4 from split-adjusted $13.32 and keeps a Buy rating on the shares. The firm is citing its expectations of dilution in cutting its price target as the company addresses capital needs to advance ATR-12 and ATR-04 forward in clinical development, the analyst tells investors in a research note. Maxim adds however that Azitra's lead program ATR-12 in Netherton syndrome reported positive initial safety data in June, and if positive, its ongoing Phase 1 trial could be a key catalyst for shares.

People Also Watch